Calprotectin, from the very beginning…
Amanda Appleton, Senior Product Manager, Alpha Laboratories Ltd., caught up with Dr Arne Roseth, a pioneer in the adoption of…
The #1 Resource for Calprotectin in the UK and Eire
The BÜHLMANN IBDoc® is an IVDR Calprotectin assay for home testing. Utilising sophisticated technology contained within smartphones, the IBDoc enables patients to perform quantitative calprotectin tests at home.
Under the guidance of clinicians, regular monitoring is now possible for IBD patients in the comfort of their own home. This approach allows for a customised, patient centric method for therapy and disease management helping to predict possible relapse and assisting with therapy optimisation.
Read the NICE Medtech innovation briefing [MIB132] on Calprotectin Home TestingClick here to take a look at our Step-by-Step guide to setting up an account on the IBDoc App
Download the IBDoc App Set-up InstructionsWith ebooks, video tutorials and helpful tips, this page has everything you need to ensure your clinic is using the IBDoc App and portal correctly.
Visit the Guidance for Clinics pageDiscover the future of healthcare at your doorstep with our all-new direct to patient kit delivery for the IBDoc calprotectin self-testing system.
Find out more about direct to patient deliveryIBDoc® Home Test | |||
---|---|---|---|
Product Code | Description | Pack Size | |
LF-IBDOC8 | IBDoc Home Test Kits | 8 |
Easy as 1-2-3
The BÜHLMANN IBDoc® system, available from Alpha Laboratories, provides sophisticated technology that enables your IBD patients to perform quantitative calprotectin testing themselves, in just three easy steps, reading the results using their smartphones.
More Regular Patient Monitoring
IBDoc provides a practical way for more frequent monitoring of patients in the privacy of their own home.
Under the guidance of clinicians, more regular patient monitoring can help predict potential relapse and assist in therapy optimisation. This approach allows for a customised, patient centric approach for management of disease and therapy.
1. Prepare the Test
To start the test procedure the patient logs into the downloaded IBDoc App on their smartphone with their IBDoc account username and password. They then collect a stool sample with the easy to use faecal collection paper sheet included in the IBDoc Test Kit.
2. Extract the Sample
The sampling pin of the CALEX Valve extraction device is dipped into the stool sample a few times with a twisting motion. This collects a defined amount of stool in the grooves of the CALEX Valve pin. The pin is placed back into the tube through the upper funnel.
3. Load the Test Cassette
The CALEX Valve tube is applied onto the test cassette and a precise amount of extract is released by turning the lever. After a few seconds, when the membrane strip of the cassette gets visibly soaked, the lever is closed.
Results are read using the smartphone camera. Placing the camera above the cassette focuses and automatically takes a picture. The image is analysed through a sophisticated image processor and a quantitative result is calculated by the IBDoc App.
Using a traffic light code system the result is classified as NORMAL, MODERATE, or HIGH. All the results performed on one smartphone are saved locally and can be accessed at any future time.
The result taken with the App is automatically transferred to the IBDoc Portal and the patient’s doctor is immediately notified. Depending on the test result the doctor can communicate with the patient to advise on further therapeutic steps to be taken.
Easy Sample Extraction and Dispensing
The CALEX® Valve allows patients to process their own samples without the need for vortex mixing, centrifuging or pipetting. The valve at the base of the device dispenses a precise amount of liquid onto the lateral flow test device. After 12 minutes the calprotectin assay result is read using the smartphone and the data is transmitted to the clinician via a secure web portal.
Personal Portal for Direct Management by the Clinician
The IBDoc Portal is a secure, encrypted, user friendly application for clinical professionals to manage their IBD patients.
Each patient test profile can be tailored by the clinician:
Excellent Correlation of Results
IBDoc provides consistent results that correlate with other BÜHLMANN Calprotectin assays:
Amanda Appleton, Senior Product Manager, Alpha Laboratories Ltd., caught up with Dr Arne Roseth, a pioneer in the adoption of…
An interview with Prof. Dr. Patrick van Rheenen University Medical Center Groningen, The Netherlands Can you introduce yourself and your…
Kezia Allen, Associate Practitioner – Clinical Trials, Basildon Hospital The demands on healthcare resources continue to escalate, with the COVID…
COVID has caused many changes in our day to day lives, with freedom and services intermittently restricted as the infection…
The ongoing coronavirus pandemic means many patients with inflammatory bowel disease (IBD) are identified as high-risk and need to shield.…
Accelerating Remote Patient Monitoring During the COVID-19 Pandemic Demands on healthcare resources continue to escalate as our aging population is…
In this humbling account, Rose Stanley, wife of long term Crohn’s sufferer Lee, shares her experiences of how, together, they…
The recent merger of clinical services across Basildon, Southend and Broomfield, now forms the Mid and South Essex University Hospital…
Lee Stanley, long term Crohn’s sufferer shares his experience of managing his disease with the help of calprotectin self-testing. “Having…
The Benefits for Patients and Healthcare Staff of Routine IBDoc® Use The Mercy University Hospital in Cork is a designated…
Gastrointestinal/IBD Nurse of the Year 2018 introduces calprotectin home testing at her hospital. Pearl Avery of Dorset County Hospital NHS Trust has…
At the European Crohn’s and Colitis Organisation, 13th Congress in Vienna in February 2018 Avery and Wilson of Dorset County Hospital Foundation Trust, Gastroenterology,…
Using IBDoc Faecal Calprotectin Testing Post Induction of anti-TNF Therapy G. Elsafi et al. Department of Gastroenterology, Mercy University Hospital,…
Mary O’Connell née Deasy, Biochemistry Department, Mercy University Hospital, Cork, Ireland The Mercy University hospital is one of the largest users…
NEW User Report: Monitoring calprotectin concentrations is important as an indicator of disease activity, the effectiveness of treatment and to…
At the British Society of Gastroenterology Annual Meeting in Liverpool in June 2016, a poster was presented by a team…
Crohn’s sufferer Lee Stanley from Manchester writes about his experience of living with Crohn’s Disease for 25 years. Why he…
“Using the IBDoc has increased the engagement from both the patients and the clinical team, and the speed of the results really makes a big impact in decision making and patient management.”
Mid and South Essex University Hospital Trust
New Interview!
Innovative IBD Care: How the IBDoc® is Empowering Patients at County Durham & Darlington NSHFT